More on SCNX
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $0.29 |
|
|||
| Open | $0.28 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $0.29 | ||||
| Day Low | $0.28 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 308,982 | ||||
- Form 8-K Scienture Holdings, Inc. For: Sep 14
- Scienture signs deal to sell Rezenopy at 2,000 addiction clinics
- SCIENTURE Expands Commercial Reach of REZENOPY™ to Addiction Treatment Centers through an Agreement with a Distribution Partner
- Form DEF 14A Scienture Holdings, Inc. For: Sep 18
- Form 8-K Scienture Holdings, Inc. For: Sep 14
- SCIENTURE to Present at the H.C. Wainwright 28th Annual Global Investment Conference on September 14, 2026
- Form 8-K Scienture Holdings, Inc. For: Aug 14
- SCIENTURE Reports Q2 2026 Results with Approximately 510% Sequential Revenue Growth from Q1 2026 and Significant Improvement in Operating Performance
- Form 10-Q Scienture Holdings, Inc. For: Jun 30
- Scienture launches 10mg naloxone nasal spray Rezenopy nationwide
Entities mentioned with SCNX
- FDA | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Definitive Agreement | View Related Stories »
- Earnings | View Related Stories »
- S1 | View Related Stories »
- S3 | View Related Stories »
- Show More...
